Seidman Cancer Center
Showing of 61 results
UH Seidman Cancer Center Researcher Awarded New Gastrointestinal Cancer Grant from NCCN in Collaboration with Taiho Oncology, Inc.
Dr. Madison Conces was awarded for a Phase II Clinical Trial of Trifluridine/Tipiracil plus Oxaliplatin in Patients with Advanced or Metastatic Biliary Tract Cancer Following First-Line Therapy.
UH Cleveland Medical Center Activates AI for Early Lung Cancer Identification
‘Second set of eyes’ aims to help physicians find small pulmonary nodules
Researchers at University Hospitals, Case Western Reserve to begin clinical testing with new, less-invasive technology to screen for esophageal precancer
Study supported by $8 million National Institutes of Health grant.
Cholesterol Drug Repurposed as Investigational Therapy for HPV+ Cancers at University Hospitals Seidman Cancer Center in Nation’s First-Ever Clinical Trials
UH Seidman Cancer Center will soon begin to look into the use of fenofibrate as a potential treatment for HPV+ cancers.
University Hospitals to Invest $39 Million to Build Regional Cancer Hub at UH TriPoint Medical Center
Regional hub will help better serve patients east of Cleveland; Oncology services will also be expanded at UH Minoff Health Center in Beachwood.
University Hospitals Seidman Cancer Center is one of the first in North America to offer Varian Ethos 2.0 for cancer patients
The radiation treatment allows for unprecedented targeting of tumors while sparing healthy organs in almost a dozen different types of cancer.
University Hospitals fundraising campaign, Because of You, surpasses $1.5 billion in community support
Campaign crosses milestone with momentum in pursuit of $2 billion goal.
Phase 1 BAFF CAR T Clinical Trial for Patients with Relapsed and Refractory Multiple Myeloma Underway at UH Seidman Cancer Center
Study is being done through an agreement between UH and Luminary Therapeutics.